Startup inspiration can strike anywhere. But for Atlas.co*, a freemium browser-based, real-time mapping tool that's being ...
A founder who was an early mover in the race to build autonomous vehicles has raised $15 million for his next act: a startup ...
William Blair analyst Sami Corwin maintained a Buy rating on PTC Therapeutics (PTCT – Research Report) today. The company’s shares closed yesterday at $42.96. Corwin covers the Healthcare sector, ...
The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...
Baird analyst Joe Vruwink raised the firm’s price target on PTC (PTC) to $228 from $226 and keeps an Outperform rating on the shares. The ...